Clinical observation on pathologic myopia CNV treated with intravitreal bevacizumab

Clinical observation on pathologic myopia CNV treated with intravitreal bevacizumab

AIM: To evaluate the efficacy and safety of intravitreal bevacizumab(Avastin)for choroidal neovascularization(CNV)in pathologic myopia(PM)by including optical coherence tomography(OCT), fluorescein angiography(FFA)and best-corrected visual acuity(BCVA). METHODS: Totally 42 eyes in 41 patients wi...

Full description

Bibliographic Details
Main Authors: Zheng-Qun Liu, Xiao-Hua Zhu, Hui Yue
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-05-01
Series:Guoji Yanke Zazhi
Subjects:
vascular endothelium growth factor
pathological myopia
choroidal nevascularization
Avastin
Online Access:http://www.ies.net.cn/cn_publish/2013/5/201305034.pdf

Internet

http://www.ies.net.cn/cn_publish/2013/5/201305034.pdf

Similar Items